English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Horizon Pharma
Robert Hadley
| Jun 17, 2017
U.S. court sides with Horizon Pharma in patent infringement claim regarding Pennsaid
Chandra Lye
| May 4, 2017
FDA approves use of Ravicti to treat urea cycle disorders in younger pediatric patients
Ruth de Jauregui
| Mar 31, 2017
Horizon Pharma presents new data on Ravicti
Gene Johnson
| Mar 24, 2017
Horizon Pharma launches initiative for people with rare genetic disease
Jireh Gibson
| Mar 19, 2017
Horizon Pharma launches initiative to raise awareness of people affected by rare diseases
Trending
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+
Pharmaceuticals
Patient Daily
| Jun 25, 2025
Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
